The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Population variation of common cystic fibrosis mutations
Abstract
Since the identification of the gene and the major mutation responsible for cystic fibrosis (CF) in 1989, more than 400 presumed mutations and about 90 DNA sequence variations have been identified in the cystic fibrosis transmembrane conductance regulator (CFTR) gene in the past 4 years. A list of CFTR mutations can be found in an earlier report in this journal (Tsui, 1992). While ∆F508 appears to be common in all study populations its relative frequency varies among different geographic locations (CF Genetic Analysis Consortium, 1990). The distribution of other CF mutations has also been found to be heterogeneous among different populations. In fact, most of the described mutations have only been detected in the original reported cases. \n \nTo obtain a better understanding of the distribution of the relatively common mutations in the world population, CF mutation screening data were collected for the 30 most common mutations from members of the CF Genetic Analysis Consortium in October 1993. The list of mutations was chosen according to an earlier compilation completed in May 1992 (unpublished data). As the updated test results show, there were only 19 mutations, each detected on 50 or more chromosomes. The center-by-center distribution for 24 of the more commons mutations is shown in Table 1 and the distribution by continent is summarized in Table 2. Two of the previously surveyed mutations, namely, Y122X and 3905insT, are included in Table 3. The three other mutations that were surveyed but not reported here are Q493X, S549R (T→G), and 3849 + 4A→G (≤20 chromosomes each; actual numbers available from L. C. Tsui). \n \nSince the broad survey could have missed some of the mutations that are present in substantial proportion (i.e. ≥1%) in some study populations, members of the Consortium were also asked to submit data for such unique mutations not listed in Tables 1 and 2. The results are displayed in Table 3. Most notably, 394delTT is a mutation that was not included in the previous survey but detected on more than 50 chromosomes. \n \nIt is important to note that the frequencies reported here are the best estimate provided by each participating group. The investigators (up to 3 listed per group) responsible for each data set are shown in the respective tables as contributors to this report. Although an effort has been made to minimize the redundant data, there may be a slight overlap of samples. Moreover, the data presented here are essentially derived from testing CF patients; the frequencies shown may not reflect the true proportion of these mutations in the respective populations due to possible sampling bias. Some of the data have appeared in previous reports. Because of the large number of entries, however, references are only cited for the original mutation descriptions. \n \nIn conclusion, this report has compiled population data to document that there is a striking difference in the distribution of CFTR mutations in different populations; the overall detection rate for the 24 most common mutations surveyed varies from 50% to 97% (Tables 1,2). This information is important when designing strategies for DNA testing of cystic fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of the Cystic Fibrosis Gene: Genetic Analysis
Kerem, B.-S., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., & Tsui, L.-C. (1989) · Science · doi:10.1126/science.2570460 · Cited by 4,142
Kerem, B. S., Zielenski, J., Markiewicz, D., Bozon, D., Gazit, E., Yahav, J., Kennedy, D., Riordan, J. R., Collins, F. S., & Rommens, J. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.21.8447 · Cited by 421
Cutting, G. R., Kasch, L. M., Rosenstein, B. J., Zielenski, J., Tsui, L.-C., Antonarakis, S. E., & Kazazian Jr, H. H. (1990) · Nature · doi:10.1038/346366a0 · Cited by 398
Dean, M., White, M. B., Amos, J., Gerrard, B., Stewart, C., Khaw, K.-T., & Leppert, M. (1990) · Cell · doi:10.1016/0092-8674(90)90196-l · Cited by 343
Fanen, P., Ghanem, N., Vidaud, M., Besmond, C., Martin, J., Costes, B., Plassa, F., & Goossens, M. (1992) · Genomics · doi:10.1016/0888-7543(92)90152-i · Cited by 269
Tsui, L.-C. (1992) · Human Mutation · doi:10.1002/humu.1380010304 · Cited by 177
Zielenski, J., Bozon, D., Kerem, B.-S., Markiewicz, D., Durie, P., Rommens, J. M., & Tsui, L.-C. (1991) · Genomics · doi:10.1016/0888-7543(91)90504-8 · Cited by 166
Vidaud, M., Fanen, P., Martin, J., Ghanem, N., Nicolas, S., & Goossens, M. (1990) · Human Genetics · doi:10.1007/bf02428305 · Cited by 120
A mutation in the second nucleotide binding fold of the cystic fibrosis gene.
Osborne, L. R., Knight, R. A., Santis, G., & Hodson, M. E. (1991) · Europe PMC (PubMed Central) · Cited by 115
Gasparini, P., Nunes, V., Savoia, A., Dognini, M., Morral, N., Gaona, A., Bonizzato, A., Chillón, M., Sangiuolo, F. C., Novelli, G., et al. (1991) · Genomics · doi:10.1016/0888-7543(91)90500-e · Cited by 111
Claustres, M., Laussel, M., Desgeorges, M., Giansily, M., Culard, J.-F., Razakatsara, G., & DEMAILLE, J. G. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.8.1209 · Cited by 99
Cuppens, H., Marynen, P., Boeck, C. D., & Cassiman, J. (1993) · Genomics · doi:10.1016/s0888-7543(05)80376-3 · Cited by 72
Jones, C. T., Mclntosh, L., Keston, M., Ferguson, A. T., & Brock, D. J. H. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.1.11 · Cited by 63
(1993) · Europe PMC (PubMed Central) · Cited by 59
Bozon, D., Zielenski, J., Rininsland, F. H., & Tsui, L. (1994) · Human Mutation · doi:10.1002/humu.1380030329 · Cited by 59
Cremonesi, L., Ferrari, M., Belloni, E., Magnani, C., Seia, M., Ronchetto, P., Rady, M., Russo, M. P., Romeo, G., & Devoto, M. (1992) · Human Mutation · doi:10.1002/humu.1380010409 · Cited by 46
Kälin, N., Dörk, T., & Tümmler, B. (1992) · Human Mutation · doi:10.1002/humu.1380010305 · Cited by 42
Mercier, B., Lissens, W., Audrézet, M. ‐., Bonduelle, M., Liebaers, I., & Férec, C. (1993) · Human Mutation · doi:10.1002/humu.1380020104 · Cited by 29
Identification of a nonframeshift 84-bp deletion in exon 13 of the cystic fibrosis gene.
Granell, R., Solera, J., Carrasco, S., & Molano, J. (1992) · Europe PMC (PubMed Central) · Cited by 23
Bisceglia, L., Grifa, A., Zelante, L., & Gasparini, P. (1994) · Human Mutation · doi:10.1002/humu.1380040208 · Cited by 23
Schwarz, M. J., Summers, C., Heptinstall, L., Newton, C., Markham, A. F., & Super, M. (1991) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5934-0_48 · Cited by 20
A termination mutation (2143delT) in the CFTR gene of German cystic fibrosis patients
D�rk, T., K�lin, N., Stuhrmann, M., Schmidtke, J., & T�mmler, B. (1992) · Human Genetics · doi:10.1007/bf00220079 · Cited by 17
Ravnik‐Glavač, M., Glavač, D., Komel, R., & Dean, M. C. (1993) · Human Mutation · doi:10.1002/humu.1380020408 · Cited by 17
A novel mutation in exon 3 of the CFTR gene
Guillermit, H., J�hanne, M., Qu�r�, I., Audr�zet, M. P., Mercier, B., & F�rec, C. (1993) · Human Genetics · doi:10.1007/bf00218262 · Cited by 15
Cited by
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Gibson, R. L., Burns, J. L., & Ramsey, B. W. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-505so · Cited by 1,633
The diagnosis of cystic fibrosis: A consensus statement
Rosenstein, B. J., & Cutting, G. R. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70344-0 · Cited by 1,086
Bobadilla, J. L., Macek, M., Fine, J. P., & Farrell, P. M. (2002) · Human Mutation · doi:10.1002/humu.10041 · Cited by 1,032
Relation between Mutations of the Cystic Fibrosis Gene and Idiopathic Pancreatitis
Cohn, J. A., Friedman, K. J., Noone, P. G., Knowles, M. R., Silverman, L. M., & Jowell, P. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809033391002 · Cited by 928
Global prevalence of putative haemochromatosis mutations.
Merryweather-Clarke, A. T., Pointon, J. J., Shearman, J. D., & Robson, K. J. (1997) · Journal of Medical Genetics · doi:10.1136/jmg.34.4.275 · Cited by 789
Metadata
- Authors
- The Cystic Fibrosis Genetic Analysis Consortium
- Venue
- Human Mutation
- Publisher
- Hindawi Limited
- Published
- 1994
- Volume
- 4
- Issue
- 3
- Pages
- 167-177
- ISSN
- 1059-7794 (ISSN-L)
- 1098-1004
- OpenAlex
- W1547921699
- Cited by
- 309
- References
- 24
- FWCI
- 33.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.